Real‐world effectiveness and safety of dupilumab in patients with moderate and severe atopic dermatitis: 2‐year experience

Abstract Objective Dupilumab has been deemed highly effective for atopic dermatitis (AD). However, there have been no reports performing a combination analysis with hematological data and improvement rates pertaining to the continued use of dupilumab for up to 2 years in real world. In this study, w...

Full description

Saved in:
Bibliographic Details
Main Authors: Chisako Fujiwara (Author), Akihiko Uchiyama (Author), Yuta Inoue (Author), Mai Ishikawa (Author), Sei‐ichiro Motegi (Author)
Format: Book
Published: Frontiers Media S.A., 2023-06-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available